Google creates $300 million fund for late stage funding for European biotech firms

The new fund will provide funding to both public and private firms for products that have already reached mid-stage Phase II clinical development, providing them with a new source of growth capital. In a move that underscores the wide net Google has cast across industries, the search engine giant has sunk in $300 million in…